Safety of lumbar puncture in adult patients with acute lymphoblastic leukemia and thrombocytopenia: A retrospective study
Abstract
Abstract Introduction: Acute lymphoblastic leukemia (ALL) requires lumbar punctures (LPs) for central nervous system (CNS) diagnosis and treatment. Guidelines suggest a platelet threshold of ≥50×10⁹/L; however, patients often present with thrombocytopenia. Evidence on the safety of performing LPs with low platelet counts in adults is limited. Objective: To evaluate the association between thrombocytopenia and adverse events (AEs) following LP in adults with ALL. Methods: Retrospective study conducted at the Instituto Nacional de Cancerología (Mexico, 2017–2023). We included 185 adult ALL patients, totaling 442 LPs. LPs were categorized by pre-procedure platelet count: ≥100×10⁹/L, 50–99×10⁹/L, and <50×10⁹/L. Hemorrhagic events, traumatic LPs, headache, and other AEs were assessed. Statistical tests compared groups. Results: Median age was 33.7 years; 68.6% were young adults. 93.5% had B-cell ALL, and 17.8% had CNS involvement. 72.4% had thrombocytopenia at diagnosis, with 30.8% having <20×10⁹/L. Overall, 13 hemorrhagic events (2.9%) were identified, with no significant difference between platelet groups (*p*=0.7891). A total of 46 LP-associated AEs (10.4%) were recorded, primarily headache (9.2%), puncture-site bleeding, subdural hematoma, and seizures. AE incidence was higher in thrombocytopenic groups (*p*=0.003), though grade III–IV events were rare (*n*=2) and not significantly different (*p*=0.8074). Traumatic LP rates were similar across platelet categories (*p*=0.9473). Prophylactic transfusion practices varied. Among patients with <50×10⁹/L, 79 transfusions were administered, with no significant differences in headache or puncture-site bleeding between transfused and non-transfused patients (*p*>0.4). One subdural hematoma occurred in a transfused patient. Conclusions: In our study, thrombocytopenia <50×10⁹/L was not associated with increased risk of severe bleeding or traumatic LP. However, the optimal safety threshold remains uncertain, with emerging literature suggesting ≥30×10⁹/L. Operator skill may be a key factor in procedural safety. Multicenter prospective studies are needed to establish optimal thresholds.
Article Details
Authors (5)
Andres Yesid Bonilla Salcedo
1National Cancer Institute, ., Mexico
Maria Ana Robles Rodriguez
1National Cancer Institute, ., Mexico
Omar Fernandez Vargas
1Instituto Nacional de Cancerología - México, Hematology, Mexico City, Mexico
Maria Fernanda Martinez Franco
1National Cancer Institute, ., Mexico
Victor Itaí Urbalejo Ceniceros
1National Cancer Institute, ., Mexico